| Date Filed | Type | Description |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2023 |
4
| MCDADE MARK (Director) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Granted 17,000 options to buy
@ $9.89, valued at
$168.1k
|
|
| 06/08/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Granted 17,000 options to buy
@ $9.89, valued at
$168.1k
|
|
| 06/08/2023 |
4
| Wassil Jim (Director) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Granted 17,000 options to buy
@ $9.89, valued at
$168.1k
|
|
| 06/08/2023 |
4
| Veneman Ann M (Director) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Granted 17,000 options to buy
@ $9.89, valued at
$168.1k
|
|
| 06/08/2023 |
4
| Shiver John W. (Director) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Granted 17,000 options to buy
@ $9.89, valued at
$168.1k
|
|
| 06/08/2023 |
4
| FIELDS HEIDI (Director) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Granted 17,000 options to buy
@ $9.89, valued at
$168.1k
|
|
| 05/25/2023 |
4
| Cearley Cassia (Chief Business Officer) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Sold 10,000 shares
@ $10, valued at
$100k
|
|
| 04/05/2023 |
4
| Holtzman Douglas (Chief Scientific Officer) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Sold 20,143 shares
@ $6.0785, valued at
$122.4k
Sold 300 shares
@ $6.56, valued at
$2k
Exercised 20,443 options to buy
@ $1.04, valued at
$21.3k
|
|
| 03/08/2023 |
4
| Cearley Cassia (Chief Business Officer) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Sold 5,000 shares
@ $7.7474, valued at
$38.7k
|
|
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2023 |
4
| Simpson Adam K. (CEO) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Exercised 2,395 options to buy
@ $0.84, valued at
$2k
Exercised 10,678 options to buy
@ $1.04, valued at
$11.1k
|
|
| 12/23/2022 |
4
| Simpson Adam K. (CEO) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Sold 66,764 shares
@ $8.963, valued at
$598.4k
Exercised 14,369 options to buy
@ $0.84, valued at
$12.1k
|
|
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2022 |
4
| Bekiroglu Elizabeth (General Counsel & Corp. Sec.) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Sold 1,813 shares
@ $4.8731, valued at
$8.8k
|
|
| 08/02/2022 |
4
| Simpson Adam K. (CEO) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Sold 2,456 shares
@ $7.1076, valued at
$17.5k
Sold 7,017 shares
@ $6.6374, valued at
$46.6k
Sold 1,904 shares
@ $6.7038, valued at
$12.8k
|
|
| 08/02/2022 |
4
| Russo Thomas Joseph (CFO) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Sold 639 shares
@ $7.1076, valued at
$4.5k
Sold 1,825 shares
@ $6.6374, valued at
$12.1k
Sold 495 shares
@ $6.7038, valued at
$3.3k
|
|
| 08/02/2022 |
4
| Holtzman Douglas (Chief Scientific Officer) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Sold 585 shares
@ $7.1076, valued at
$4.2k
Sold 9,337 shares
@ $6.6374, valued at
$62k
Sold 453 shares
@ $6.7038, valued at
$3k
Gifted 20,000 shares
@ $0 |
|
| 08/02/2022 |
4
| Richardson Charles E (SVP, Technical Operations) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Sold 479 shares
@ $7.1076, valued at
$3.4k
Sold 1,368 shares
@ $6.6374, valued at
$9.1k
Sold 371 shares
@ $6.7038, valued at
$2.5k
|
|
| 08/02/2022 |
4
| Kanesa-thasan Niranjan (Chief Medical Officer) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Sold 701 shares
@ $7.1076, valued at
$5k
Sold 2,001 shares
@ $6.6374, valued at
$13.3k
Sold 543 shares
@ $6.7038, valued at
$3.6k
|
|
| 08/02/2022 |
4
| Cearley Cassia (Chief Business Officer) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Sold 391 shares
@ $7.1076, valued at
$2.8k
Sold 1,118 shares
@ $6.6374, valued at
$7.4k
Sold 303 shares
@ $6.7038, valued at
$2k
|
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|